Parkinson's Foundation
14
3
5
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
2 terminated/withdrawn out of 14 trials
66.7%
-19.8% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait
Role: collaborator
Effects of Vagal Nerve Stimulation on Leg Muscle Activity and Posture in Parkinson's Disease
Role: collaborator
Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Role: collaborator
Parkinson's Foundation PD GENEration Genetic Registry
Role: lead
Imaging a Cholinergic Biomarker of Cognition in Parkinson's Disease
Role: collaborator
Trial of Parkinson's And Zoledronic Acid
Role: collaborator
Stochastic Resonance Stimulation Effect on Gait Stability in Parkinson Disease
Role: collaborator
PDGeneration: Mapping the Future of Parkinson's Disease
Role: lead
The Effect of Vibrotactile Stimulation on Parkinson's Tremor
Role: collaborator
The Effects of Vibrotactile Stimulation in Patients With Movement Disorders
Role: collaborator
Group Versus Individuals Telehealth Exercise Programs for People With Parkinson Disease
Role: collaborator
Parkinson's Foundation Surveys
Role: lead
Brain Activity During Gait in Parkinson's
Role: collaborator
Aquatic Group Exercise for People With Parkinson Disease
Role: collaborator
All 14 trials loaded